Supplementary Figure S5 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

<p>Supplementary Figure 5: Copy number variants in the three main glioblastoma groups according to classifier v12.5. A Copy number variants in all patients combined (n = 295), B in RTK1 tumors (n = 89), C in RTK2 tumors (n = 140) and D in MES tumors (n = 66). PDGFRA amplifications are enriched...

全面介绍

Saved in:

书目详细资料
主要作者:	Tobias Kessler (17079209) (author)
其他作者:	Daniel Schrimpf (17079212) (author), Laura Doerner (17079215) (author), Ling Hai (17079218) (author), Leon D. Kaulen (17079221) (author), Jakob Ito (17079224) (author), Martin van den Bent (17079227) (author), Martin Taphoorn (17079230) (author), Alba A. Brandes (17079233) (author), Ahmed Idbaih (17079236) (author), Julien Dômont (17079239) (author), Paul M. Clement (15044256) (author), Mario Campone (15027156) (author), Martin Bendszus (17079242) (author), Andreas von Deimling (15037904) (author), Felix Sahm (15097382) (author), Michael Platten (15018165) (author), Wolfgang Wick (15018168) (author), Antje Wick (17079245) (author)
出版:	2025
主题:	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine
标签:	添加标签没有标签, 成为第一个标记此记录!

Supplementary Figure S5 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

相似书籍